Phase 3 Chronic Obstructive Pulmonary Disease trials recruiting now

All Chronic Obstructive Pulmonary Disease trials, every phase

Other phases for Chronic Obstructive Pulmonary Disease

Phase 3 Chronic Obstructive Pulmonary Disease trials

• Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
  NCT07190209 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 221 locations
• Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
  NCT07190222 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 214 locations
• Long-term Safety and Tolerability of Tozorakimab in Patients With COPD and History of Exacerbations
  NCT07566195 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female) · 13 locations
• Tadalafil for Severe Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease
  NCT05844462 · Phase: Phase 3 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location

Common questions

What does Phase 3 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.